Covista Inc. (CVSA) FY2025 10-K Annual Report
Covista Inc. (CVSA) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Aug 7, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Covista Inc. FY2025 10-K Analysis
Business Overview
- • Core business: Provider of postsecondary education with focus on medical and healthcare programs
- • Emphasis on regulatory compliance risks impacting Title IV funding and clinical placement limitations for medical schools
- • Strategic focus on expansion via campus openings, new programs, and acquisitions despite regulatory and integration challenges
- • Goodwill and intangible assets of $961.3M and $765.5M respectively, representing 63% of total assets as of June 30, 2025
- • Authorized $150M share repurchase program through 2028 with full authorization still available as of June 2025
Management Discussion & Analysis
- • No revenue or profit figures disclosed in the MD&A section
- • Key risk: potential fines, debt discharge liabilities, or suspension from Title IV programs due to "substantial misrepresentation" claims
- • Best/worst segment details not provided; focus on risk of institutional non-compliance with ED regulatory standards
- • No cash flow, capital allocation, buybacks, dividends, or capex information given
- • Forward-looking risk: enforcement actions or restrictions by ED may materially affect operations, financial condition, and cash flows
Risk Factors
- • Regulatory risk from U.S. Department of Education (ED) Borrower Defense to Repayment rules affecting Title IV loan obligations recovery
- • Geopolitical exposure to U.S. federal and state investigations, risking Title IV program eligibility restrictions across multiple institutions
- • Operational risk from potential loss of accreditation or degree-granting authority due to regulatory non-compliance outcomes
- • Competitive threat from adverse publicity and regulatory scrutiny impacting student enrollment relative to other proprietary education providers
- • Financial risk from potential large monetary judgments or fines exceeding existing insurance coverage, impacting cash flows and results
Covista Inc. FY2025 Key Financial MetricsXBRL
Revenue
$1.8B
▲ +12.9% YoY
Net Income
$237M
▲ +73.3% YoY
Operating Margin
19.1%
▲ +540bp YoY
Net Margin
13.3%
▲ +463bp YoY
ROE
16.5%
▲ +655bp YoY
Total Assets
$2.8B
▲ +0.4% YoY
EPS (Diluted)
$6.18
▲ +82.3% YoY
Operating Cash Flow
$338M
▲ +14.2% YoY
Source: XBRL data from Covista Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Covista Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.